A First-in-Human Study of LY2409021 in Healthy Participants and Participants With Type 2 Diabetes

Clinical trial NCT01606371 · COMPLETED

Trial details

NCT number: NCT01606371
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2007-05-01
Primary completion: 2007-10-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.